News


Gene Therapy Pioneer Jim Wilson Comments on iECURE's Announcement of Complete Clinical Response for ECUR-506

January 9, 2025

Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences's Announcement of FDA IND Clearance for Friedreich's Ataxia Treatment

January 8, 2025

GEMMABio Appoints Dr. May Orfali as Chief Medical Officer

December 23, 2024

GEMMABio Secures $34 Million in Seed Funding to Drive Gene Therapy Advancements

GEMMABio Announces $100 Million Agreement with Brazil's Leading Health Research Institute

October 8, 2024

To Further Advance Gene Therapy Research, Industry Pioneer Jim Wilson is Forming Two Independent Companies Dedicated to Genetic Medicine

July 31, 2024